Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pilot Study of TTI-0102 in Cystinosis
NCT07837726Phase 2Not yet recruiting
- Sponsor
- Thiogenesis Therapeutics
- Start
- Oct 2026
- Primary completion
- Dec 2026
01
Overview
A Phase 2 trial of cysteamine-pantetheine disulfide in cystinosis, sponsored by Thiogenesis Therapeutics. Planned start Oct 2026; status: not yet recruiting.
02
Drugs
cysteamine-pantetheine disulfide
03
Conditions
cystinosis
Beyond the preview
Go deeper on NCT07837726.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07837726.